Market Cap 2.25B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 15,607,700
Avg Vol 8,212,914
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 99%
Beta 1.17
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
MrHurts
MrHurts Jun. 29 at 3:01 AM
$ABCL very possible we will hit $10 this week 🚀🚀🚀
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jun. 29 at 1:23 AM
$ABCL how many days to cover 😏
0 · Reply
8008track
8008track Jun. 29 at 12:50 AM
$ABCL nothing to see here…
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 29 at 12:23 AM
$ABCL $ABCL ripping overnight again 👀
1 · Reply
JennyRowes
JennyRowes Jun. 28 at 8:05 PM
$ABCL if you are new to ABCL this is the video to watch. https://youtu.be/X8q_qZgqSRw?si=Gm5TEnxq-hV0REMu
1 · Reply
tradersunion353
tradersunion353 Jun. 28 at 6:47 PM
$ABCL 10 dollars next week please demamp and other clowns who wants abcl to forever trade at $3 so they can add and load.. 🖕🖕🖕🖕🖕
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 28 at 6:11 PM
$ABCL $ABCL Momentum breakout out on the monthly 👀 Monthly breakouts on $ABCL with volume confirmation like this don't come often, solid setup to watch. first monthly close above 200sma since IPO
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 28 at 5:55 PM
$ABCL $ABCL hold the phone. Read this passage. Could AbCellera potentially be dabbling in de novo design of antibodies? Biological data is the rarest currency in AI-driven drug discovery. If that's true, $ABCL may have been compounding one of the most valuable currencies in biotech for years.
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jun. 28 at 4:12 PM
$ABCL i think its more due to Tcell work with $ABBV but I’m sure $JAZZ saw promise with 635 and 575
0 · Reply
tranq19
tranq19 Jun. 28 at 8:25 AM
$ABCL that would be great, but in a double blind placebo controlled study that’s highly unlikely. Carl may have antidotal info on how the trial is going, but actual phase 2 material data unlikey. That said, i believe the phase 1 results were a factor and overall the deal is a strong vote of confidence
0 · Reply
Latest News on ABCL
AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 23 days ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 6 weeks ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 6 weeks ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 7 weeks ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 2 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 4 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 4 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 5 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 8 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 8 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 10 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 10 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 11 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


MrHurts
MrHurts Jun. 29 at 3:01 AM
$ABCL very possible we will hit $10 this week 🚀🚀🚀
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jun. 29 at 1:23 AM
$ABCL how many days to cover 😏
0 · Reply
8008track
8008track Jun. 29 at 12:50 AM
$ABCL nothing to see here…
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 29 at 12:23 AM
$ABCL $ABCL ripping overnight again 👀
1 · Reply
JennyRowes
JennyRowes Jun. 28 at 8:05 PM
$ABCL if you are new to ABCL this is the video to watch. https://youtu.be/X8q_qZgqSRw?si=Gm5TEnxq-hV0REMu
1 · Reply
tradersunion353
tradersunion353 Jun. 28 at 6:47 PM
$ABCL 10 dollars next week please demamp and other clowns who wants abcl to forever trade at $3 so they can add and load.. 🖕🖕🖕🖕🖕
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 28 at 6:11 PM
$ABCL $ABCL Momentum breakout out on the monthly 👀 Monthly breakouts on $ABCL with volume confirmation like this don't come often, solid setup to watch. first monthly close above 200sma since IPO
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 28 at 5:55 PM
$ABCL $ABCL hold the phone. Read this passage. Could AbCellera potentially be dabbling in de novo design of antibodies? Biological data is the rarest currency in AI-driven drug discovery. If that's true, $ABCL may have been compounding one of the most valuable currencies in biotech for years.
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jun. 28 at 4:12 PM
$ABCL i think its more due to Tcell work with $ABBV but I’m sure $JAZZ saw promise with 635 and 575
0 · Reply
tranq19
tranq19 Jun. 28 at 8:25 AM
$ABCL that would be great, but in a double blind placebo controlled study that’s highly unlikely. Carl may have antidotal info on how the trial is going, but actual phase 2 material data unlikey. That said, i believe the phase 1 results were a factor and overall the deal is a strong vote of confidence
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 28 at 7:39 AM
$ABCL $ABCL Biotech Healthcare is one of the strong sectors in the current market.
0 · Reply
Amires
Amires Jun. 28 at 5:31 AM
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 28 at 4:16 AM
$ABCL Didn't even realize $ABCL is most likely going to get a monthly close over the 200week SMA for the first time ever. If you're a bear, you're cooked.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 28 at 3:13 AM
$ABCL Golden Egg
0 · Reply
Rastafari
Rastafari Jun. 27 at 11:08 PM
$ABCL I’ve worked in sales for many years and have negotiated multimillion-dollar deals, so I’m very familiar with the negotiation process. My feeling about the Jazz deal is that Jazz’s executives met with Carl to finalize the agreement under one key condition: they wanted to review the preliminary ABCL635 data before signing. My thesis is that the early results must have been encouraging, and that gave Renee Gala the confidence to move forward and sign the deal with Carl. That’s just my interpretation, of course. What do you all think?
2 · Reply
bonecrack_benny
bonecrack_benny Jun. 27 at 7:01 PM
$ABCL Monday…. What a scene we will witness. Dear me.
2 · Reply
PikaBullRun
PikaBullRun Jun. 27 at 4:17 PM
$ABCL has rallied over 150% since its previous low. From a structural perspective, the price action remains within an upward technical wave. Based on the current chart pattern, the longer term upside targets can be projected around the $10 to $12 range.
0 · Reply
Doozio
Doozio Jun. 27 at 3:28 PM
After da $ABCL s go da $XYZ are NXT ENTA 🐒🍌🧠⏰♾️
0 · Reply
6digitmidget
6digitmidget Jun. 27 at 2:16 PM
$ABCL holding this plus SLS made for a great close to the week.
0 · Reply
S2K_TP
S2K_TP Jun. 27 at 12:59 PM
$RLAY $ABCL $ALXO my favorite Bio trio 🚨🔥
0 · Reply
S2K_TP
S2K_TP Jun. 27 at 12:47 PM
$ABCL 10+ on deck by EOY
2 · Reply
bonecrack_benny
bonecrack_benny Jun. 27 at 7:15 AM
$ABCL Massive
0 · Reply